Showing posts with label histone deacetylase inhibitor. Show all posts
Showing posts with label histone deacetylase inhibitor. Show all posts
Tuesday, March 23, 2010
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours.
CONCLUSIONS: Belinostat is well tolerated in both patient groups and shows some activity in patients with micropapillary (LMP) disease.
Subscribe to:
Posts
(
Atom
)
